Cesium carbonate → 1-[5-(3-Chloro-5-{[4-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)-1,3-thiazol-2-yl]cyclobutanol
反応式
[NH2:1][C:2]1[CH:3]=[C:4]([C:9]2[S:13][C:12]([C:14]3([OH:18])[CH2:17][CH2:16][CH2:15]3)=[N:11][CH:10]=2)[CH:5]=[C:6]([Cl:8])[CH:7]=1.Cl[C:20]1[N:25]=[C:24]([C:26]([F:29])([F:28])[F:27])[CH:23]=[CH:22][N:21]=1.CC1(C)C2C(=C(P(C3C=CC=CC=3)C3C=CC=CC=3)C=CC=2)OC2C(P(C3C=CC=CC=3)C3C=CC=CC=3)=CC=CC1=2.C(=O)([O-])[O-].[Cs+].[Cs+]>C(OCC)(=O)C.C([O-])(=O)C.[Pd+2].C([O-])(=O)C.O1CCOCC1>[Cl:8][C:6]1[CH:5]=[C:4]([C:9]2[S:13][C:12]([C:14]3([OH:18])[CH2:17][CH2:16][CH2:15]3)=[N:11][CH:10]=2)[CH:3]=[C:2]([NH:1][C:20]2[N:25]=[C:24]([C:26]([F:29])([F:28])[F:27])[CH:23]=[CH:22][N:21]=2)[CH:7]=1参加物
反応物 4
生成物 1
試薬・触媒・溶媒 3
実験手順
The product of Step 3 (460 mg, 1.720 mmol), 2-chloro-4-(trifluoromethyl)pyrimidine (314 mg, 1.638 mmol), Xantphos (284 mg, 0.492 mmol), palladium (II) acetate (73.6 mg, 0.328 mmol), cesium carbonate (1.068 g, 3.28 mmol) and dioxane (12.3 mL) were heated at 90° C. for 90 minutes. The reaction mixture was diluted with ethyl acetate, washed with water and dried over Na2SO4. Filtration and solvent evaporation gave a residue which was further purified by column chromatography on silica gel, eluting with 40% ethyl acetate in hexane to afford 1-[5-(3-chloro-5-{[4-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)-1,3-thiazol-2-yl]cyclobutanol as a brown solid (390 mg, 55.8%). 1H NMR (500 MHz, CDCl3): δ 8.71 (d, J=4.7 Hz, 1H); 7.92 (s, 1H); 7.85 (s, 1H); 7.78 (s, 1H); 7.69 (s, 1H); 7.25 (s, 1H); 7.13 (d, J=4.8 Hz, 1H); 3.81 (s, 1H); 2.73 (s, 2H); 2.58-2.47 (m, 2H); 2.13-1.97 (m, 2H) MS APCI: [M+H]+ m/z 427.1. rhSYK activity=++
後処理
- washwashed with water
- dry with materialdried over Na2SO4
- filtrationFiltration and solvent evaporation
- customgave a residue which
- customwas further purified by column chromatography on silica gel
- washeluting with 40% ethyl acetate in hexane
出典と根拠
- ORDレコード
- ord-95e6165e45894bd5ae60a4a7b8ec13f5
- 出典データセット
- uspto-grants-2013_10
- 特許番号
- US08551984B2
反応ノート
読み込み中…